Trial Profile
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Advanced breast cancer; Early breast cancer
- Focus Therapeutic Use
- 16 Jul 2011 New trial record